Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...
NUV-868 is under clinical development by Nuvation Bio and currently in Phase II for Triple-Negative Breast Cancer (TNBC).
NUV-868 is under clinical development by Nuvation Bio and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II drugs for Peritoneal Cancer have a 37% phase transition success ...
Hosted on MSN23h
Richard Hays, influential scholar who changed his mind on same-sex marriage, has diedThe renowned New Testament scholar and former dean of Duke Divinity School described his most recent book as an act of ...
Jane Street Group LLC cut its holdings in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) by 6.8% during ...
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) insider Mark Lackner sold 4,411 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold ...
A groundbreaking study led by Flinders University in Australia has revealed that circular RNAs, a recently discovered type of ...
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback